MAPK3 and Alzheimer disease: Here, we showed for the first time that the progression of AD-like pathology in OXYS rats takes place simultaneously with alterations in the expression of nine genes encoding proteins participating in the ERK1/2 SP, whereas dietary supplementation with SkQ1 normalizes the expression of eight of these genes.